Chemicals and Drugs

Gemtuzumab

Immunotoxin that consists of an anti-CD33 (CD33 ANTIGEN) monoclonal antibody conjugated to CALICHEAMICIN. It is used for the treatment of ACUTE MYELOID LEUKEMIA.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

Immunotoxin that consists of an anti-CD33 (CD33 ANTIGEN) monoclonal antibody conjugated to CALICHEAMICIN. It is used for the treatment of ACUTE MYELOID LEUKEMIA.

MeSH Record

Classification

Broader headings

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

Drug Class

Pharmacological Action

MeSH Record

Synonyms

6 entry terms
  • CMA 676
  • CMA-676
  • Gemtuzumab Ozogamicin
  • Gemtuzumab-Ozogamicin
  • Mylotarg
  • CMA676

MeSH Record

Aspects Covered

22 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, analysis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.

MeSH Record

History Note

2020 (2000)

MeSH Hierarchy

Tree Numbers

  1. D09w.408w.051.247w.500
  2. D12.776w.124w.486.485.114w.224w.060w.790
  3. D12.776w.124w.790.651.114w.224w.060w.790
  4. D12.776w.377w.715.548.114w.224w.200w.790

AMA Style

References

  1. National Library of Medicine. Gemtuzumab. Medical Subject Headings (MeSH). 2026. Unique ID D000079982. http://id.nlm.nih.gov/mesh/2026/D000079982
  2. Gemtuzumab. In: Wikidata. https://www.wikidata.org/wiki/Q105946712